Literature DB >> 16904838

CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: are patients with pulmonary emphysema also candidates for SBRT for lung cancers?

Tomoki Kimura1, Kanji Matsuura, Yuji Murakami, Yasutoshi Hashimoto, Masahiro Kenjo, Yuko Kaneyasu, Koichi Wadasaki, Yutaka Hirokawa, Katsuhide Ito, Motoomi Okawa.   

Abstract

PURPOSE: The purpose of this study was to analyze the computed tomographic (CT) appearance of radiation injury to the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) and evaluate the difference by the presence of pulmonary emphysema (PE) for small lung cancers. METHODS AND MATERIALS: In this analysis, 45 patients with 52 primary or metastatic lung cancers were enrolled. We evaluated the CT appearance of acute radiation pneumonitis (within 6 months) and radiation fibrosis (after 6 months) after SBRT. Clinical symptoms were evaluated by Common Terminology Criteria for Adverse Events, version 3.0. We also evaluated the relationship between CT appearance, clinical symptoms, and PE.
RESULTS: CT appearance of acute radiation pneumonitis was classified as follows: (1) diffuse consolidation, 38.5%; (2) patchy consolidation and ground-glass opacities (GGO), 15.4%; (3) diffuse GGO, 11.5%; (4) patchy GGO, 2.0%; (5) no evidence of increasing density, 32.6%. CT appearance of radiation fibrosis was classified as follows: (1) modified conventional pattern, 61.5%; (2) mass-like pattern, 17.3%; (3) scar-like pattern, 21.2%. Patients who were diagnosed with more than Grade 2 pneumonitis showed significantly less no evidence of increased density pattern and scar-like pattern than any other pattern (p=0.0314, 0.0297, respectively). Significantly, most of these patients with no evidence of increased density pattern and scar-like pattern had PE (p=0.00038, 0.00044, respectively).
CONCLUSION: Computed tomographic appearance after SBRT was classified into five patterns of acute radiation pneumonitis and three patterns of radiation fibrosis. Our results suggest that SBRT can be also safely performed even in patients with PE.

Entities:  

Mesh:

Year:  2006        PMID: 16904838     DOI: 10.1016/j.ijrobp.2006.05.008

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  29 in total

1.  Patterns of CT lung injury and toxicity after stereotactic radiotherapy delivered with helical tomotherapy in early stage medically inoperable NSCLC.

Authors:  S Arcangeli; L Agolli; L Portalone; M R Migliorino; M G Lopergolo; A Monaco; J Dognini; M C Pressello; S Bracci; V Donato
Journal:  Br J Radiol       Date:  2015-02-03       Impact factor: 3.039

2.  Is severe emphysema, as defined by quantitative CT measurement, a negative risk factor of radiation fibrosis?

Authors:  Tatsuhiko Saito; Hidetsugu Nakayama; Takafumi Yamada; Sachica Shiraishi; Koichi Tokuuye
Journal:  Br J Radiol       Date:  2018-04-20       Impact factor: 3.039

Review 3.  Radiation pneumonitis after stereotactic radiation therapy for lung cancer.

Authors:  Hideomi Yamashita; Wataru Takahashi; Akihiro Haga; Keiichi Nakagawa
Journal:  World J Radiol       Date:  2014-09-28

Review 4.  Pulmonary Function Changes After Radiotherapy for Lung or Esophageal Cancer: A Systematic Review Focusing on Dose-Volume Parameters.

Authors:  Anne G H Niezink; Renske A de Jong; Christina T Muijs; Johannes A Langendijk; Joachim Widder
Journal:  Oncologist       Date:  2017-05-26

Review 5.  Current status of stereotactic body radiotherapy for lung cancer.

Authors:  Yasushi Nagata; Yukinori Matsuo; Kenji Takayama; Yoshiki Norihisa; Takashi Mizowaki; Michihide Mitsumori; Keiko Shibuya; Shinsuke Yano; Yuichiroh Narita; Masahiro Hiraoka
Journal:  Int J Clin Oncol       Date:  2007-02-25       Impact factor: 3.402

6.  No differences in radiological changes after 3D conformal vs VMAT-based stereotactic radiotherapy for early stage non-small cell lung cancer.

Authors:  Serena Badellino; Jacopo Di Muzio; Giulia Schivazappa; Alessia Guarneri; Riccardo Ragona; Sara Bartoncini; Elisabetta Trino; Andrea Riccardo Filippi; Paolo Fonio; Umberto Ricardi
Journal:  Br J Radiol       Date:  2017-09-04       Impact factor: 3.039

7.  Radiation pneumonitis in patients with lung and mediastinal tumours: a retrospective study of risk factors focused on pulmonary emphysema.

Authors:  T Kimura; T Togami; H Takashima; Y Nishiyama; M Ohkawa; Y Nagata
Journal:  Br J Radiol       Date:  2011-03-08       Impact factor: 3.039

8.  Treatment outcomes and patterns of radiologic appearance after hypofractionated image-guided radiotherapy delivered with helical tomotherapy (HHT) for lung tumours.

Authors:  Stefano Arcangeli; Lorenzo Falcinelli; Stefano Bracci; Alessandro Greco; Alessia Monaco; Jessica Dognini; Cinzia Chiostrini; Rita Bellavita; Cynthia Aristei; Vittorio Donato
Journal:  Br J Radiol       Date:  2017-03       Impact factor: 3.039

9.  Comparison of clinical, tumour-related and dosimetric factors in grade 0-1, grade 2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours.

Authors:  A Takeda; T Ohashi; E Kunieda; N Sanuki; T Enomoto; T Takeda; Y Oku; N Shigematsu
Journal:  Br J Radiol       Date:  2012-01-17       Impact factor: 3.039

10.  Patients with severe emphysema have a low risk of radiation pneumonitis following stereotactic body radiotherapy.

Authors:  M Ishijima; H Nakayama; T Itonaga; Y Tajima; S Shiraishi; M Okubo; R Mikami; K Tokuuye
Journal:  Br J Radiol       Date:  2014-12-09       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.